Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Publications
Features
Glossary
Links
Quotations
References
About
Search
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Publications
Features
Glossary
Links
Quotations
References
About
Blog
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
When Healthy Policy Neglects Economic Principles, Patients Suffer
Raymond March
-
October 13, 2018
FDA Still Hooked on Meddling in Nicotine Markets
FDA Struggles to Develop “Sugar Added” Labels for Honey and Maple Syrup
Let Competition, Not the FDA, Resolve the EpiPen Shortage
Government vs. Private Efforts to Promote Breastfeeding: My Response to a Critic
FDA Considers Regulating E-cigarette Juices
Raymond March
-
September 1, 2018
0
FDA Approves Medical App for Contraception
Raymond March
-
August 22, 2018
0
Open Up Off-Label Drug Communication and Let the Market Work!
Raymond March
-
August 7, 2018
0
Three Reasons To Be Optimistic about Pharmaceutical Policy
Raymond March
-
August 2, 2018
0
If Telemedicine Is Underachieving, Government Is to Blame
Raymond March
-
July 11, 2018
0
Misdiagnosing Right-to-try Laws
Raymond March
-
July 6, 2018
0
Putting Right-to-Try Drug Prices in Perspective
Raymond March
-
July 2, 2018
0
EpiPen Pricing Controversy Reveals Ignorance about Market Competition
Raymond March
-
June 22, 2018
0
FDA Moves Closer to Approving Ecstasy
Raymond March
-
June 19, 2018
0
Right-to-Try Law Signed!
Raymond March
-
June 18, 2018
0
1
2
3
Page 1 of 3
Edit with Live CSS
